Vimarsana
Biggest News Aggregation in the World

Page 22 - Accessed August News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Accessed August. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Accessed August Today - Breaking & Trending Today

Simulation Demonstrates Potential Effectiveness of Model-Informed Precision Dosing for Heparin - Vimarsana News

Simulation Demonstrates Potential Effectiveness of Model-Informed Precision Dosing for Heparin

The growing awareness in health care of the challenges associated with proper dosing of anticoagulants such as heparin has inspired the emerging field of anticoagulation stewardship.

FDA Allows Continuation of Phase 1/2 Trial of ONCT-534 in mCRPC - Vimarsana News

FDA Allows Continuation of Phase 1/2 Trial of ONCT-534 in mCRPC

The FDA has approved a study may proceed letter in advance of its 30-day review period to Oncternal Therapeutics for its phase 1/2 study evaluating ONCT-534, a novel dual-action AR inhibitor in patients with mCRPC who have relapsed or are refractory to approved AR signaling inhibitors.

Lack of Clinical Benefit Leads to End of Development for Etrumadenant in mCRPC - Vimarsana News

Lack of Clinical Benefit Leads to End of Development for Etrumadenant in mCRPC

The development of etrumadenant as a potential treatment option for patients with metastatic castration-resistant prostate cancer will be discontinued after data from the phase 1/2 ARC-6 trial did not demonstrate a sufficient clinical benefit for etrumadenant plus zimberelimab and docetaxel compared with docetaxel alone.

MDNA11 Generates Activity, Safety in Advanced Solid Tumors - Vimarsana News

MDNA11 Generates Activity, Safety in Advanced Solid Tumors

Treatment with the long-acting interleukin-2 superkine led to durable tumor control and no dose-limiting toxicities in patients with advanced solid tumors, according to data from the dose-escalation portion of the phase 1/2 ABILITY-1 trial.

Stranded Pacific walrus calf under care of Alaska SeaLife Center - Vimarsana News

Stranded Pacific walrus calf under care of Alaska SeaLife Center

First walrus patient at Alaska SeaLife Center in 4 years making this case a notable one and excellent opportunity for all involved to learn more about the species

Source: dvm360.com